Weight Loss and Appetite Reduction After Percutaneous Electrical Stimulation Dermatome T6
1 other identifier
interventional
200
0 countries
N/A
Brief Summary
The patients are randomized into 4 groups : Patients undergoing PENS of dermatome T6 in and a 1200 Kcal diet (Group 1), Patients undergoing PENS T6 and a 2000 Kcal/day, Patients undergoing transcutaneous electrical neurostimulation (TENS) of Dermatomes T11-T12 and following a 1200 Kcal diet and those patients following only a 1200 Kcal diet (Group 4). Weight loss, appetite and ghrelin levels at baseline and after treatment are investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jul 2015
Shorter than P25 for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 21, 2016
CompletedFirst Posted
Study publicly available on registry
June 23, 2016
CompletedJune 23, 2016
June 1, 2016
5 months
June 21, 2016
June 21, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Weight loss
Weight loss will be evaluated after 12 weeks of treatment
After 12 weeks of treatment
Study Arms (4)
PENS T6 and 1200 Kcal/day diet
EXPERIMENTALPatients undergo 12 sessions of percutaneous electrical stimulation of dermatome T6 (PENS T6), weekly, during 12 weeks. During this period they follow a hypocaloric 1200 Kcal/day diet.
PENST6 + Normocaloric 2000 Kcal/day diet
ACTIVE COMPARATORPatients undergo 12 sessions of percutaneous electrical stimulation of dermatome T6 (PENS T6), weekly, during 12 weeks. During this period they follow a normocaloric 2000 Kcal/day diet.
TENS T11/ T12 + 1200 Kcal/day diet
PLACEBO COMPARATORPatients undergo 12 sessions of transcutaneous electrical stimulation of dermatomes T11-T12 , weekly, during 12 weeks. During this period they follow a hypocaloric 1200 Kcal/day diet.
1200 Kcal/day diet
ACTIVE COMPARATORPatients follow only a hypocaloric 1200 Kcal/day diet.
Interventions
Patients undergo percutaneous electrical stimulation of dermatome T6, weekly, during 12 weeks.
Patients undergo transcutaneous electrical stimulation of dermatomes T11-T12, weekly, during 12 weeks.
Patients follow a Hypocaloric 1200 Kcal/day diet during 12 weeks.
Patients follow a Normocaloric 2000 Kcal/day diet during 12 weeks.
Eligibility Criteria
You may qualify if:
- Patients with obesity (BMI\>30 Kg/m2) or overweight (BMI 25-30 Kg/m2)
You may not qualify if:
- Untreated endocrine disease causing obesity
- Serious psychiatric illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dolores Castro
Clinica Garcilaso
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Neurostimulation Unit. Garcilaso Clinic
Study Record Dates
First Submitted
June 21, 2016
First Posted
June 23, 2016
Study Start
July 1, 2015
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
June 23, 2016
Record last verified: 2016-06
Data Sharing
- IPD Sharing
- Will share
Data might be published in a journal, always preserving patients´ confidentiality.